dacarbazine and Aura

dacarbazine has been researched along with Aura in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, B; Dhruv, H; Eschbacher, JM; Kloss, J; Loftus, JC; Ross, JT; Schumacher, CA; Tran, NL; Tuncali, S; Williams, BO; Yang, Z1
Chinot, O; Cloughesy, T; Gilbert, MR; Gorlia, T; Happold, C; Hegi, M; Mehta, MP; Nabors, LB; Perry, JR; Pugh, SL; Reardon, DA; Roth, P; Stupp, R; Weller, M; Wick, W1
Albani, F; Baruzzi, A; Contin, M; Dinapoli, L; Fabi, A; Jandolo, B; Maschio, M; Pace, A; Zarabla, A1
Dinapoli, L; Maschio, M; Muti, P; Vidiri, A1
Blasco, J; Bruna, J; Gil, M; Graus, F; Pineda, E; Simó, M; Velasco, R; Verger, E1
Glass, J; Nei, M; Ngo, L1
Laigle-Donadey, F; Sanson, M1
Dalmau, J; de la Fuente, BP; Rosenfeld, M1

Reviews

2 review(s) available for dacarbazine and Aura

ArticleYear
[Pattern of care of high-grade gliomas].
    La Revue du praticien, 2006, Oct-31, Volume: 56, Issue:16

    Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Epilepsy; Forecasting; Genetic Markers; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Oligodendroglioma; Prognosis; Quality of Life; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Survival Analysis; Temozolomide; Thromboembolism; Time Factors; Tomography, X-Ray Computed

2006
[Glioma therapy up-date].
    Neurologia (Barcelona, Spain), 2007, Volume: 22, Issue:3

    Topics: Anticoagulants; Anticonvulsants; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Dacarbazine; DNA Damage; Drug Administration Schedule; Epilepsy; Forecasting; Glioblastoma; Glioma; Humans; Neoplasm Proteins; O(6)-Methylguanine-DNA Methyltransferase; Palliative Care; Prognosis; Promoter Regions, Genetic; Temozolomide; Thrombophilia

2007

Trials

1 trial(s) available for dacarbazine and Aura

ArticleYear
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy.
    Journal of neuro-oncology, 2008, Volume: 90, Issue:2

    Topics: Adult; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carbamazepine; Dacarbazine; Epilepsy; Female; Follow-Up Studies; Fructose; Humans; Male; Middle Aged; Oxcarbazepine; Temozolomide; Topiramate; Young Adult

2008

Other Studies

5 other study(ies) available for dacarbazine and Aura

ArticleYear
TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.
    Molecular cancer research : MCR, 2013, Volume: 11, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis; Astrocytes; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Chickens; Dacarbazine; Drug Resistance, Neoplasm; Epilepsy; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioblastoma; Humans; Mice; Mice, Nude; Mice, Transgenic; Neoplasm Invasiveness; NF-kappa B; Proto-Oncogene Proteins c-akt; Receptors, Tumor Necrosis Factor; Signal Transduction; Temozolomide; Xenograft Model Antitumor Assays

2013
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Mar-01, Volume: 34, Issue:7

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Clinical Trials as Topic; Dacarbazine; Epilepsy; Female; Glioblastoma; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prognosis; Survival Analysis; Temozolomide; Valproic Acid

2016
Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy.
    Journal of neurology, 2010, Volume: 257, Issue:11

    Topics: Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Carbamazepine; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Epilepsy; Exanthema; Female; Humans; Male; Middle Aged; Oxcarbazepine; Radiotherapy; Temozolomide

2010
Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy.
    Journal of neuro-oncology, 2012, Volume: 108, Issue:3

    Topics: Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Dacarbazine; Epilepsy; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Grading; Prognosis; Prospective Studies; Survival Rate; Temozolomide; Thrombocytopenia

2012
Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma.
    Epilepsia, 2006, Volume: 47, Issue:7

    Topics: Adult; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Comorbidity; Dacarbazine; Drug Resistance; Epilepsy; Humans; Magnetic Resonance Imaging; Male; Oligodendroglioma; Temozolomide; Treatment Outcome

2006